HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Plasminogen and plasminogen proactivator in liver diseases.

Abstract
The behaviour of plasminogen (PLg) and plasminogen proactivator (PPLg) and some currently employed enzyme parameters were prospectively studied in 1047 subjects, of whom: 748 patients with liver diseases and jaundice; 52 tumor patients and 247 healthy persons. The patients with parenchymal liver diseases showed significantly reduced PLg and PPLg activity in direct relation with the severity and the stage of diseases. In patients with obstructive jaundice the activity of the fibrinolytic enzymes was usually normal, rarely increased. Other parameters such as: ALAT, LAP, G--GT and bilirubin were elevated most often in patients with viral hepatitis as well as in patients with obstructive jaundice. Quick time was found less affected during acute viral hepatitis and acute liver failure. It seems possible to recommend PLg and PPLg as liver function tests in association with the other function tests.
AuthorsH P Boyadjian, R N Bakalova
JournalMedecine interne (Med Interne) 1988 Oct-Dec Vol. 26 Issue 4 Pg. 291-6 ISSN: 0377-1202 [Print] Romania
PMID3244988 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Plasminogen
  • Plasminogen Activators
Topics
  • Hepatitis, Viral, Human (blood, diagnosis)
  • Humans
  • Jaundice (blood, diagnosis)
  • Liver Diseases (blood, diagnosis)
  • Liver Function Tests
  • Liver Neoplasms (blood, diagnosis)
  • Plasminogen (analysis)
  • Plasminogen Activators (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: